cycloserine has been researched along with Alzheimer Disease in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (70.59) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Ahangar, N; Babaei, P; Badrikoohi, M; Nikseresht, Z | 1 |
| Goetghebeur, PJD; Targum, SD; Wesnes, KA | 1 |
| Alam, P; Asmat, S; Chaturvedi, SK; Khan, JM; Khan, RH; Qadeer, A; Siddique, IA; Zaidi, N; Zaidi, Y | 1 |
| Brown, P; Daly, EJ; Falk, WE; Gunther, J; Tsai, GE | 1 |
| Fonnum, F; Myhrer, T; Oksengård, AR; Paulsen, RE; Wangen, K | 1 |
| Bravi, D; Chase, TN; Mouradian, MM; Randolph, C; Roberts, JW; Tierney, MC | 1 |
| Benes, C; Cutler, NR; Fakouhi, TD; Hantsburger, G; Herting, R; Jhee, SS; Schwartz, P; Sramek, JJ; Swabb, EA | 1 |
| Deutsch, SI; Hashtroudi, S; Herting, RL; Schwartz, BL; Schwartz, P | 1 |
| Herting, R; Knott, V; Mendis, T; Mohr, E; Sampson, M; Wesnes, K | 1 |
| Falk, WE; Gunther, J; Tsai, GE | 1 |
| Ikonen, S; Riekkinen, M; Riekkinen, P | 1 |
| Coyle, JT; Falk, WE; Gunther, J; Tsai, GE | 1 |
| Laake, K; Oeksengaard, AR | 1 |
| Bowen, DM; Francis, PT; Procter, AW; Young, AB | 1 |
| Bowen, DM; Francis, PT; Pangalos, MN; Procter, AW; Stephens, PH | 1 |
| Bowen, DM; Chessell, IP; Francis, PT; Procter, AW | 1 |
| Bowen, DM | 1 |
2 review(s) available for cycloserine and Alzheimer Disease
| Article | Year |
|---|---|
D-cycloserine for Alzheimer's disease.
Topics: Alzheimer Disease; Anti-Infective Agents, Urinary; Antibiotics, Antitubercular; Cycloserine; Humans; Randomized Controlled Trials as Topic | 2002 |
Treatment of Alzheimer's disease. Molecular pathology versus neurotransmitter-based therapy.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Cerebral Cortex; Chromosomes, Human, Pair 21; Cloning, Molecular; Cycloserine; Glutamates; Glutamic Acid; Humans; Neurotransmitter Agents; Protease Inhibitors; Protein Precursors; Receptors, N-Methyl-D-Aspartate | 1990 |
7 trial(s) available for cycloserine and Alzheimer Disease
| Article | Year |
|---|---|
D-Cycloserine Improves Difficult Discriminations in a Pattern Separation Task in Alzheimer's Disease Patients with Dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antimetabolites; Cycloserine; Dementia; Double-Blind Method; Female; Humans; Male; Middle Aged; Pattern Recognition, Visual; Photic Stimulation; Psychomotor Performance | 2019 |
D-cycloserine treatment of Alzheimer disease.
Topics: Aged; Alzheimer Disease; Brain; Cycloserine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Geriatric Assessment; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Receptors, N-Methyl-D-Aspartate | 1994 |
Evaluation of cycloserine in the treatment of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antibiotics, Antitubercular; Cognition Disorders; Cycloserine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Placebos | 1995 |
d-Cycloserine enhances implicit memory in Alzheimer patients.
Topics: Aged; Alzheimer Disease; Cycloserine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Learning; Male; Memory; Placebos | 1996 |
Cognitive and quantified electroencephalographic correlates of cycloserine treatment in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition; Cycloserine; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Female; Humans; Male | 1995 |
A preliminary study of D-cycloserine treatment in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Cognition; Cross-Over Studies; Cycloserine; Double-Blind Method; Excitatory Amino Acid Agonists; Female; Humans; Male; Neuropsychological Tests; Pilot Projects; Treatment Outcome | 1998 |
Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.
Topics: Aged; Alzheimer Disease; Cognition; Cognition Disorders; Cycloserine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Glycine; Humans; Male; Memory; Middle Aged; Placebos; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate | 1999 |
8 other study(ies) available for cycloserine and Alzheimer Disease
| Article | Year |
|---|---|
Synergistic enhancing-memory effect of D-serine and RU360, a mitochondrial calcium uniporter blocker in rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antimetabolites; Behavior, Animal; Brain-Derived Neurotrophic Factor; Calcium Channels; CREB-Binding Protein; Cycloserine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Agonists; Hippocampus; Male; Memory Disorders; Peptide Fragments; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Ruthenium Compounds | 2021 |
Unraveling Comparative Anti-Amyloidogenic Behavior of Pyrazinamide and D-Cycloserine: A Mechanistic Biophysical Insight.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antibiotics, Antitubercular; Chickens; Cycloserine; Muramidase; PC12 Cells; Peptide Fragments; Protein Aggregates; Pyrazinamide; Rats | 2015 |
A case series of D-cycloserine added to donepezil in the treatment of Alzheimer's disease.
Topics: Adolescent; Adult; Alzheimer Disease; Antimetabolites; Child; Cholinesterase Inhibitors; Cognition Disorders; Cycloserine; Donepezil; Drug Therapy, Combination; Humans; Indans; Neuropsychological Tests; Piperidines | 2002 |
Role of glutamate and glutamate receptors in memory function and Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Animals; Cognition; Cycloserine; Discrimination Learning; Entorhinal Cortex; Female; Glutamic Acid; Humans; Male; Memory; N-Methylaspartate; Rats; Receptors, Glutamate; Temporal Lobe | 1995 |
D-cycloserine, a partial NMDA receptor-associated glycine-B site agonist, enhances reversal learning, but a cholinesterase inhibitor and nicotine has no effect.
Topics: Alzheimer Disease; Animals; Antimetabolites; Binding Sites; Cholinesterase Inhibitors; Conditioning, Psychological; Cycloserine; Denervation; Glycine; Maze Learning; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reversal Learning; Septal Nuclei; Tacrine | 1998 |
Treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Cerebral Cortex; Cycloserine; Humans; Neuropsychological Tests; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Synaptic Transmission | 1992 |
Treatment strategies for Alzheimer's disease.
Topics: Alzheimer Disease; Cycloserine; Humans; Receptors, Neurotransmitter; Serotonin Antagonists | 1992 |
D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition; Cycloserine; Dizocilpine Maleate; Female; Humans; Ionophores; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Stereoisomerism | 1991 |